Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Bencycloquidium bromide
- Development stage
- Phase 4
- Lead developer
- Silver Valley Pharmaceutical
- Modality
- Small Molecules
- Administration
- Intranasal, Inhalation
01
Overview
Bencycloquidium bromide is a novel small molecule anticholinergic drug that acts as a selective muscarinic M1 and M3 receptor antagonist. It is primarily developed for the treatment of allergic rhinitis and related symptoms such as rhinorrhea (runny nose), sneezing, nasal congestion, and itching. The drug is administered intranasally or by inhalation. Its mechanism involves competitively blocking acetylcholine at muscarinic receptors in the nasal mucosa or airways, thereby reducing glandular secretions and smooth muscle spasms associated with allergic responses. Clinical trials have demonstrated its efficacy and safety in patients with persistent allergic rhinitis[1][3][4][6][8]. The developer of bencycloquidium bromide is Yingu Pharmaceutical.
- Brand names
- BilipidineBILITING
- Other names
- bencycloquidium bromideBCQBBilipidineBILITING
02
Targets
M1 (Muscarinic acetylcholine receptor M1)CHRM3 (M3)
Beyond the preview
Go deeper on Bencycloquidium bromide.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Bencycloquidium bromide.